<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34497481</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1557-0703</ISSN><JournalIssue CitedMedium="Internet"><Volume>2021</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Occupational therapy international</Title><ISOAbbreviation>Occup Ther Int</ISOAbbreviation></Journal><ArticleTitle>The Assistive Device Situation for ALS Patients in Norway.</ArticleTitle><Pagination><StartPage>5563343</StartPage><MedlinePgn>5563343</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">5563343</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2021/5563343</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">There are limited analytical descriptions of the assistive device situation in Norway for patients with ALS and other motor neuron diseases. This study is aimed at investigating how patients, caregivers, and healthcare professionals (occupational therapists and physiotherapists) experience the assistive device situation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Twenty-four interviews were conducted with patients with motor neuron disease, caregivers, and healthcare professionals involved in procurement and adaptation of assistive devices. Systematic text condensation was used to analyse the interviews.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The majority of patients and caregivers had positive experiences of follow-up by the specialist healthcare service. Several found follow-up by the primary health service to be deficient owing to inadequate expertise, continuity, and resources. Healthcare professionals reported having a proactive approach to identifying needs for assistive devices, but for various reasons, application processes were often delayed. Several patients indicated a reluctance to use assistive devices and were ambivalent regarding proactivity. The availability of assistive devices for some functional impairments was described as inadequate. Some patients felt there was too little focus on sexuality in the follow-up. The respondents had a number of suggestions for improving the assistive device situation.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Multidisciplinary ALS teams are found to ensure follow-up expertise and continuity. Healthcare professionals wish to take a proactive approach to assistive devices, but a number of bureaucratic obstacles occur. The study findings are preliminary and should be validated through a prospective national quality registry for motor neuron diseases.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Jenny Pernilla Rolland et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rolland</LastName><ForeName>Jenny Pernilla</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0003-4359-4761</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, 7491 Trondheim, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Myrberget</LastName><ForeName>Mari-Anne</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Clinical Services, St. Olav's University Hospital, 7006 Trondheim, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meisingset</LastName><ForeName>Tore Wergeland</ForeName><Initials>TW</Initials><Identifier Source="ORCID">0000-0003-2295-123X</Identifier><AffiliationInfo><Affiliation>Institute of Neuromedicine and Movement Science, Norwegian University of Science and Technology, 7491 Trondheim, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology and Neurophysiology, St. Olav's University Hospital, 7006 Trondheim, Norway.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Occup Ther Int</MedlineTA><NlmUniqueID>9433361</NlmUniqueID><ISSNLinking>0966-7903</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Occup Ther Int. 2022 Oct 25;2022:9807421</RefSource><PMID Version="1">36381268</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009788" MajorTopicYN="Y">Occupational Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012656" MajorTopicYN="Y">Self-Help Devices</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Tore Wergeland Meisingset is a shareholder in a start-up company (established 2021) that develops exoskeletons for medical use. Remaining authors report no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34497481</ArticleId><ArticleId IdType="pmc">PMC8390132</ArticleId><ArticleId IdType="doi">10.1155/2021/5563343</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ticozzi N., Silani V. Genotypic and Phenotypic Heterogeneity in Amyotrophic Lateral Sclerosis. Springer Nature; 2018.</Citation></Reference><Reference><Citation>Majmudar S., Wu J., Paganoni S. Rehabilitation in amyotrophic lateral sclerosis: why it matters. Muscle &amp; Nerve. 2014;50(1):4&#x2013;13. doi: 10.1002/mus.24202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24202</ArticleId><ArticleId IdType="pmc">PMC4433000</ArticleId><ArticleId IdType="pubmed">24510737</ArticleId></ArticleIdList></Reference><Reference><Citation>Creemers H., Beelen A., Grupstra H., Nollet F., van den Berg L. H. The provision of assistive devices and home adaptations to patients with ALS in the Netherlands: patients&#x2019; perspectives. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2014;15(5-6):420&#x2013;425. doi: 10.3109/21678421.2014.920031.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.920031</ArticleId><ArticleId IdType="pubmed">24899120</ArticleId></ArticleIdList></Reference><Reference><Citation>Connors K. A., Mahony L. M., Morgan P. Adaptive equipment use by people with motor neuron disease in Australia: a prospective, observational consecutive cohort study. Disability and Rehabilitation. Assistive Technology. 2019;14(1):62&#x2013;67. doi: 10.1080/17483107.2017.1396623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17483107.2017.1396623</ArticleId><ArticleId IdType="pubmed">29082797</ArticleId></ArticleIdList></Reference><Reference><Citation>Bromberg M. B., Brownell A. A., Forshew D. A., Swenson M. A timeline for predicting durable medical equipment needs and interventions for amyotrophic lateral sclerosis patients. Amyotrophic Lateral Sclerosis. 2010;11(1-2):110&#x2013;115. doi: 10.3109/17482960902835970.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960902835970</ArticleId><ArticleId IdType="pubmed">19412817</ArticleId></ArticleIdList></Reference><Reference><Citation>Radunovi&#x107; A., Mitsumoto H., Leigh P. N. Clinical care of patients with amyotrophic lateral sclerosis. The Lancet Neurology. 2007;6(10):913&#x2013;925. doi: 10.1016/S1474-4422(07)70244-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(07)70244-2</ArticleId><ArticleId IdType="pubmed">17884681</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Berg J. P., Kalmijn S., Lindeman E., et al. Multidisciplinary ALS care improves quality of life in patients with ALS. Neurology. 2005;65(8):1264&#x2013;1267. doi: 10.1212/01.wnl.0000180717.29273.12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000180717.29273.12</ArticleId><ArticleId IdType="pubmed">16247055</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooney J., Byrne S., Heverin M., et al. A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland. Journal of Neurology, Neurosurgery, and Psychiatry. 2015;86(5):496&#x2013;501. doi: 10.1136/jnnp-2014-309601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2014-309601</ArticleId><ArticleId IdType="pubmed">25550416</ArticleId></ArticleIdList></Reference><Reference><Citation>Malterud K. Systematic text condensation: a strategy for qualitative analysis. Scandinavian Journal of Public Health. 2012;40(8):795&#x2013;805. doi: 10.1177/1403494812465030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1403494812465030</ArticleId><ArticleId IdType="pubmed">23221918</ArticleId></ArticleIdList></Reference><Reference><Citation>Malterud K. Qualitative research: standards, challenges, and guidelines. THE LANCET. 2001;358(9280):483&#x2013;488. doi: 10.1016/S0140-6736(01)05627-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(01)05627-6</ArticleId><ArticleId IdType="pubmed">11513933</ArticleId></ArticleIdList></Reference><Reference><Citation>Funke A., Spittel S., Grehl T., et al. Provision of assistive technology devices among people with ALS in Germany: a platform-case management approach. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2018;19(5-6):342&#x2013;350. doi: 10.1080/21678421.2018.1431786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1431786</ArticleId><ArticleId IdType="pubmed">29382225</ArticleId></ArticleIdList></Reference><Reference><Citation>Henschke C. Provision and financing of assistive technology devices in Germany: a bureaucratic odyssey? The case of amyotrophic lateral sclerosis and Duchenne muscular dystrophy. Health Policy. 2012;105(2-3):176&#x2013;184. doi: 10.1016/j.healthpol.2012.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healthpol.2012.01.013</ArticleId><ArticleId IdType="pubmed">22349416</ArticleId></ArticleIdList></Reference><Reference><Citation>Leirvik A., Liverod M., Holmoy T. Quality of life of patients with amyotrophic lateral sclerosis. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 2006;126(19):2520&#x2013;2522.</Citation><ArticleIdList><ArticleId IdType="pubmed">17028632</ArticleId></ArticleIdList></Reference><Reference><Citation>Lincoln T. C., Allen C. Theme 9 Clinical trials and trial design. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2019;20(supplement 1):262&#x2013;288. doi: 10.1080/21678421.2019.1646997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1646997</ArticleId><ArticleId IdType="pubmed">31702475</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor B. Experiences of sexuality and intimacy in terminal illness: a phenomenological study. Palliative Medicine. 2014;28(5):438&#x2013;447. doi: 10.1177/0269216313519489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0269216313519489</ArticleId><ArticleId IdType="pubmed">24449801</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor B. Sexuality, intimacy and motor neurone disease: matters of concern. British Journal of Neuroscience Nursing. 2014;10(5):242&#x2013;251. doi: 10.12968/bjnn.2014.10.5.242.</Citation><ArticleIdList><ArticleId IdType="doi">10.12968/bjnn.2014.10.5.242</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz A. Do ask, do Tell. AJN The American Journal of Nursing. 2005;105(7):66&#x2013;68. doi: 10.1097/00000446-200507000-00033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000446-200507000-00033</ArticleId><ArticleId IdType="pubmed">15995397</ArticleId></ArticleIdList></Reference><Reference><Citation>Wasner M., Bold U., Vollmer T. C., Borasio G. D. Sexuality in patients with amyotrophic lateral sclerosis and their partners. Journal of Neurology. 2004;251(4):445&#x2013;448. doi: 10.1007/s00415-004-0351-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-004-0351-1</ArticleId><ArticleId IdType="pubmed">15083290</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>